Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

CAR-T Therapy market is projected to grow at a CAGR of 42.95% by 2032: Visiongain Reports Ltd

Published

on

Visiongain has published a new report entitled CAR-T Therapy Market 2022-2032. It includes profiles of CAR-T Therapy and Forecasts Market Segment by Indication {Diffuse Large B-Cell Lymphoma (DLBCL),  Acute Lymphoblastic Leukaemia (ALL), Follicular Lymphoma,  Multiple Myeloma (MM),  Other}, Market Segment by Type (Abecma, Yescarta, Kymriah, Tecartus, Others), Market Segment by  Target Antigens (CD19/CD22, BCMA, Others), Market Segment by Patient (Children, Adults, Seniors), Market Segment by End-user (Hospitals, Specialty Clinics, Other End-user),plus COVID-19 Impact Analysis and Recovery Pattern Analysis (“V”-shaped, “W”-shaped, “U”-shaped, “L”-shaped), Profiles of Leading Companies, Region and Country.

The CAR-T Therapy market was valued at US$1.9 billion in 2021 and is projected to grow at a CAGR of 42.95% during the forecast period 2022-2032.

Some of the major forces propelling the CAR-T therapy market include increase in funding from venture capitalist and government institutes and increase in global burden of cancer benefits. As per the data published by the WHO, cancer is a leading cause of death globally and caused almost 10 million deaths in 2020.

Based on current and projected population aging and growth, the American Cancer Society, Inc., predicts that the burden of cancer will increase to an estimated 29.4 million cases globally by 2040. China, with the largest population size worldwide has the highest global proportion of cancer new cases and deaths followed by Northern America in terms of new cases and fourth by cancer deaths. Increase in consumption of tobacco & alcohol, unhealthy diet, physical inactivity, and air pollution in various countries across the globe might further increase the cancer burden in future and thus fuel market growth over the forecast period.

Download Exclusive Sample of Report

https://www.visiongain.com/report/car-t-therapy-market-2022/#download_sampe_div

How has COVID-19 had Dramatically Disrupted the CAR-T Therapy Market?

The delivery of cellular therapies, such as CAR-T cells, has been dramatically disrupted by the COVID-19 pandemic. The three sections of the CAR-T cell industry that have been most impacted by the COVID-19 issue are the production & delivery of medicines, research & clinical development, and commercial operations. Supply chains supporting the production and delivery of cell- and gene-therapy (CGTs) industries are extensive, intricate, and tightly regulated. Given that the cell or the CAR-T cell gathered are both time and temperature sensitive, closing of the borders, decreased air traffic, and delayed flights had put its viability in jeopardy during the pandemic. During the pandemic, one in five cell therapy companies reported disruptions in the supply chain, while one-third reported manufacturing delays or a complete halt to operations.

How will this Report Benefit you?

Visiongain’s 253-page report provides 99 tables and 163 charts/graphs. Our new study is suitable for anyone requiring commercial, in-depth analyses for the CAR-T Therapy market, along with detailed segment analysis in the market. Our new study will help you evaluate the overall global and regional market for CAR-T Therapy. Get financial analysis of the overall market and different segments including indication, type, target antigen, patient, end user, and company size and capture higher market share. We believe that there are strong opportunities in this fast-growing CAR-T Therapy market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report will help you to improve your strategic decision-making, allowing you to frame growth strategies, reinforce the analysis of other market players, and maximise the productivity of the company.

What are the Current Market Drivers?

Increase in Funding From Venture Capitalist And Government Institutes
In the past five years around US$12 billion have been invested by venture capital (VC) firms around the globe, an additional of US$2.2 billion of funding is raised through strategic partnerships between various institutes and biopharma companies. There has also been an increase in fundings from government and other institutes to promote CAR-T cell therapies for cancer treatment. In December 2021, the National Institutes of Health (NIH) granted US$14 million to Penn Medicine as a seven-year grant for harnessing synthetic chimeric antigen receptor (CAR) T cells which will be used to deplete immune B cells and plasma cells for achieving a compatible kidney transplant for patients.

Increase In Global Burden of Cancer

As per the data published by the WHO, cancer is a leading cause of death globally and caused almost 10 million deaths in 2020. Based on current and projected population aging and growth, the American Cancer Society, Inc., predicts that the burden of cancer will increase to an estimated 29.4 million cases globally by 2040. China, with the largest population size worldwide has the highest global proportion of cancer new cases and deaths followed by Northern America in terms of new cases and fourth by cancer deaths. Increase in consumption of tobacco & alcohol, unhealthy diet, physical inactivity, and air pollution in various countries across the globe might further increase the cancer burden in future.

Download Exclusive Sample of Report

https://www.visiongain.com/report/car-t-therapy-market-2022/#download_sampe_div

Where are the Market Opportunities?

Growing use of AI in CAR-T Cell Manufacturing
In the past few years, biotechnology has advanced immensely. The use of computers has increased leading to rising demand for faster and smaller sized machines. The heterogeneity of these devices is increasing in datasets along with their volume growing robustly. Such developments are propelling the engine of artificial intelligence in medical science, which in turn is providing huge opportunity in CAR-T cell. The increased use of AI platforms are transforming the medical industry by assisting healthcare professional’s record clinical data and analyse it on a regular basis, with greater ease and fewer errors. Many of the big pharmaceutical companies are collaborating with IT solution companies with the aim to develop IT solutions and AI platforms for analyzing the large datasets generated in laboratory experiments, clinical trials and manufacturing plants.

Competitive Landscape
The major players operating in the CAR-T Therapy market are  AbbVie Inc., Amgen Inc., BioNTech SE, bluebird bio, Inc., Bristol-Myers Squibb Company, Caribou Biosciences Inc., Gilead Sciences Inc., GSK plc, Johnson & Johnson Private Limited, Novartis AG. These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launch.

Recent Developments

  • In September 2022, Arsenal Biosciences received US$220 million funding from Bristol Myers Squibb and the Softbank Vision Fund 2 that would help the company expand its research activities in advanced CAR T therapies for solid tumors
  • In May 2022, Johnson and Johnson in partnership with Legend Biotech received EU approval for its CAR-T Carvykti to treat adults with relapsed and refractory multiple myeloma.
  • In April 2022, Kite received US FDA approval for Yescarta for the treatment of adult patients with large B-cell lymphoma

To access the data contained in this document please email [email protected]

Avoid missing out by staying informed – order our report now.

To find more Visiongain research reports on the Pharma sector, click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: [email protected]

About Visiongain

Visiongain is one of the fastest-growing and most innovative independent market intelligence providers around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports, which cover 10-year forecasts, are hundreds of pages long, with in-depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets with a lot of synergies. These markets include automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customised and syndicated market research reports offer a bespoke piece of market intelligence customised to your very own business needs.

Contact:

Oliver Davison
PR at Visiongain Reports Ltd
UK Tel: +44 207 336 6100.
Email: [email protected]
Web: www.visiongain.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

A Fond Farewell: Memories to Treasure from MWC 2024

Published

on

a-fond-farewell:-memories-to-treasure-from-mwc-2024

HONG KONG, March 4, 2024 /PRNewswire/ — As IPLOOK reflects on its successful participation in MWC 2024, the company is left with countless memories, insights and opportunities that will continue to inspire its team long after the event has ended.

IPLOOK’s Impressive Showing 
IPLOOK’s booth was a hub of activity throughout the 4-day event, drawing in crowds of attendees eager to learn more about IPLOOK’s innovative core network solutions. Some of the key achievements and gains for IPLOOK at MWC 2024 included:
Strong partnerships forged: IPLOOK nailed several new partnerships with leading telecom companies, expanding its reach and impact in the industry.Positive industry coverage: IPLOOK’s presence at MWC 24 attracted the attention of industry research outlets, resulting in conversations highlighting IPLOOK’s leading position in core network market, ability of innovation and integration capability of space, air and ground communications.Brand awareness increased: The event provided an excellent opportunity for IPLOOK to raise its profile and establish itself as a leader in the core network market. Its booth attracted a number of visitors who were already aware of its role as a core network expert, eager to explore the advancements presented by IPLOOK.Valuable feedback received: IPLOOK took the opportunity to gather feedback from attendees on its products and services, which will be invaluable in driving IPLOOK’s future product development and improvements.Innovations that Stole the Show
This year’s MWC, as per its theme “Future First”, was a testament to the power of technology to transform our future life. Attendees were treated to demonstrations of the latest innovation in AIGC, AI-RAN, Open Gateway, and 6G, showcasing how these technologies can revolutionize industries and improve people’s lives.
What’s Next for IPLOOK?
As IPLOOK sets its sights on the horizon, the company is energized by the prospect of deepening connections within the telecom ecosystem and discovering the groundbreaking advancements that lie ahead at MWC’s next chapter. With a steadfast dedication to product innovation, IPLOOK will also journey to key industry events like MVNOs World Congress and AfricaCom, forging new paths into uncharted markets and showcasing its unwavering commitment to the evolution of the telecom landscape.
Contact: [email protected] IPLOOK on LinkedIn @IPLOOK Networks
Logo – https://mma.prnewswire.com/media/2037103/IPLOOK_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/a-fond-farewell-memories-to-treasure-from-mwc-2024-302078316.html

Continue Reading

Artificial Intelligence

Mobica Appoints Gary Butters as CEO, Building on Success and Fuelling Continued Growth

Published

on

mobica-appoints-gary-butters-as-ceo,-building-on-success-and-fuelling-continued-growth

LONDON, March 4, 2024 /PRNewswire/ — Mobica, the global software and engineering provider, has announced Gary Butters as their Chief Executive Officer (CEO).

 
Gary joined Mobica as Chief Revenue Officer (CRO) in November 2020 and as part of outgoing CEO Sam Kingston’s leadership team, delivered significant success, leading to Mobica’s acquisition by Cognizant in March 2023. 
This acquisition will significantly expand Cognizant’s IoT embedded software engineering capabilities as part of their overall strategy to help companies modernise technology, reimagine processes and transform experiences so they stay ahead in a fast-changing world.
 
Gary takes over the role with the remit to complete the integration of Mobica into Cognizant while continuing to deliver double-digit growth.
Mobica, which is headquartered in Manchester UK, with operations in Europe and the US, provides world-class software engineering and development expertise to many of the most recognised global brands. Founded in 2004, it serves a number of sectors, with particular expertise in the automotive, manufacturing, industrial and semiconductor industries.
In his role as CEO, Gary will continue Mobica’s vision of delivering exceptional value and innovation to it’s clients and customers, while spearheading its growth plan as demand for engineering and software expertise continues to rise.
Commenting on his appointment, Gary says:”Over the past few years, Mobica has seen demand for our world-class engineering increase significantly, particularly with the acceleration in AI and machine learning. This has seen some of the once ‘traditional’ industries such as automotive and manufacturing undergo a radical transformation. 
“As a result, companies are increasingly seeking skilled professionals – particularly in areas such as software development, AI, IoT, and data analytics – in order to stay competitive and meet evolving customer expectations. However, they are vying for a limited pool of technology talent, so access to Mobica engineering services has been vital to enable our customers to remain agile in a rapidly evolving landscape.
“Our ongoing growth is a testament to our team of dedicated ‘Mobicans’ and our unwavering dedication to delivering cutting-edge software engineering solutions. We have consistently provided clients with access to top-tier engineering talent, enabling them to drive digital transformation and achieve their business objectives. I am looking forward to working with our talented team as we continue our ambitious growth plans.”
www.mobica.com 
Photo – https://mma.prnewswire.com/media/2352612/Mobica_1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/mobica-appoints-gary-butters-as-ceo-building-on-success-and-fuelling-continued-growth-302077506.html

Continue Reading

Artificial Intelligence

Core to Cloud Partners with Cybersecurity Innovator SenseOn to Enable Comprehensive NDR and SIEM Security

Published

on

core-to-cloud-partners-with-cybersecurity-innovator-senseon-to-enable-comprehensive-ndr-and-siem-security

New strategic arrangement allows organisations to monitor identity, endpoint, network and cloud-based activity to stop threats immediately.
CIRENCESTER, England, March 1, 2024 /PRNewswire/ — Core to Cloud, a leading provider of cybersecurity services and solutions, is excited to announce a strategic alliance with SenseOn, a renowned threat detection management platform. This collaboration will empower businesses to bolster their advanced NDR and SEIM operations and secure end-to-end platforms.

In today’s integrated digital landscape, businesses rely on various systems and third-party suppliers. The launch of SenseOn’s platform marks a significant leap forward in proactive threat detection and response, offering a comprehensive solution to combat sophisticated cyber threats. Organisations can identify, detect and respond to vulnerabilities in traditional blind spots. Core to Cloud’s partnership with SenseOn aims to address these challenges by offering a comprehensive and efficient solution for managing threat detection and response.
James Cunningham, CEO and co-founder of Core to Cloud, said: “We are excited to announce our partnership with SenseOn, allowing Core to Cloud to bring our clients a more robust and complete threat detection and management solution. With an ever-changing digital landscape, our clients must be able to detect and respond to any threats within their cyber estate. This partnership offers an all-encompassing approach to managing these risks.” 
One of the critical features of this partnership is that the platform is built upon a foundation of Artificial Intelligence (AI) and Machine Learning (ML) technologies, meticulously designed to evolve alongside cyber threats. Leveraging its unique Deep Learning, SenseOn’s platform analyses vast and complex datasets, providing real-time threat detection, investigation, and autonomous response capabilities. This innovative approach and Core to Cloud’s cybersecurity expertise enables organisations to proactively address potential threats before they escalate, ensuring robust protection against evolving cyber-attacks.
SenseOn’s platform and Core to Cloud’s know-how empower security teams to navigate the complicated threat landscape efficiently. Intelligent automation streamlines incident response, allowing cybersecurity professionals to focus on strategic initiatives rather than routine tasks.
David Atkinson, CEO and Founder of SenseOn, added: “We are excited to announce a pivotal moment in SenseOn’s journey with establishing a strategic channel partnership with Core to Cloud. This collaboration is more than a partnership; it’s an alliance that leverages the strengths of both companies to propel us towards growth. By combining SenseOn’s consolidated threat detection platform with Core to Cloud’s technical and service expertise, we are poised to deliver a new standard in cybersecurity solutions.”
Moreover, Core to Cloud and SenseOn are committed to ongoing collaboration and continuous improvement. As cybersecurity threats evolve, so do the strategies and tools to counter them. This collaboration is not just a one-time solution; it represents an ongoing commitment to enhancing the cybersecurity landscape for businesses of all sizes. Core to Cloud and SenseOn will continue to work together to develop new features, refine existing tools, and provide unparalleled support to our clients.
Core to Cloud’s partnership with SenseOn signifies a major step forward in cybersecurity. By combining expertise, technology, and a shared commitment to excellence, the two companies are paving the way for businesses to navigate the complex digital landscape confidently. Together, they empower businesses to protect their NDR, SEIM and end-to-end platforms.
Photo – https://mma.prnewswire.com/media/2351719/Core_to_Cloud.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/core-to-cloud-partners-with-cybersecurity-innovator-senseon-to-enable-comprehensive-ndr-and-siem-security-302076245.html

Continue Reading

Trending